Meridian Life Sciences recently announced that it's Memphis office will manufacture recombinant protiens and cardiac antigens as part of a technology purchase that Meridian made from Vybion, Inc. These products will be used in the diagnosis of of infectious diseases and in the monitoring of human protein levels in hepatitis, HIV and cardiac disease.
This announcement is another great sign for the growing bioscience industry in Memphis and a sign that with companies like Meridian Life Sciences, Viral Antigens, Gtx and institutions like St. Jude, Memphis is a world leader in bioscience and medical manufacturing.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment